Sign Up Today and Learn More About Stimwave Technologies Stock
Invest in or calculate the value of your shares in Stimwave Technologies or other pre-IPO companies through EquityZen's platform.
Stimwave Technologies Stock (STIT)
Stimwave Technologies, a medical device company, develops and markets wireless microsize injectable medical devices for neurology markets.
About Stimwave Technologies Stock
Founded
2010
Headquarters
Scottsdale, AZ, US
Total Funding
54.7M
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Stimwave Technologies, Inc., a medical device company, engages in the development, manufacture, commercialization, and marketing of wireless microsize injectable medical devices for neurology markets. The company was formerly known as Neural Micro Incorporated. Stimwave Technologies, Inc. was incorporated in 2010 and is based in Scottsdale, Arizona.
Stimwave Technologies Press Mentions
Stay in the know about the latest news on Stimwave Technologies
Top Growth Driver In The Peripheral Nerve Stimulators Market 2025: Prevalence Of Neurological Disorders Fuels Growth
einpresswire • Mar 01, 2025
Judge Upholds Sanctions Against Ex-Stimwave CEO
law360 • Oct 31, 2024
Ex-Stimwave CEO Gets 6 Years For Dummy Implant Scheme
law360 • Jun 28, 2024
CEO gets 6-year prison sentence over useless neurostimulator component
qz • Jun 28, 2024
Stimwave Prosecutors Accused Of Brady Violation Mid-Trial
law360 • May 20, 2024
Stimwave Technologies Management
Leadership team at Stimwave Technologies
CEO
Laura Tyler Perryman
Join now and verify your accreditation status to gain access to:
- Stimwave Technologies Current Valuation
- Stimwave Technologies Stock Price
- Stimwave Technologies Management
- Available deals in Stimwave Technologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Stimwave Technologies Cap Table and Funding History by Share Class and Liquidity Preferences
- Stimwave Technologies Revenue and Financials
- Stimwave Technologies Highlights
- Stimwave Technologies Business Model
- Stimwave Technologies Risk Factors
- Stimwave Technologies Research Report from SACRA Research
Trading Stimwave Technologies Stock
How to invest in Stimwave Technologies stock?
Accredited investors can buy pre-IPO stock in companies like Stimwave Technologies through EquityZen funds. These investments are made available by existing Stimwave Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Stimwave Technologies stock?
Shareholders can sell their Stimwave Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
